PT  - JOURNAL ARTICLE
AU  - Vinall, Maria
ED  - Murphy, Sabina A.
TI  - Ezetimibe Plus Simvastatin More Beneficial Than Simvastatin Alone in Reducing Recurrent Cardiovascular Events
DP  - 2015 May 24
TA  - MD Conference Express
PG  - 18--19
VI  - 15
IP  - 5
4099  - http://mdc.sagepub.com/content/15/5/18.short
4100  - http://mdc.sagepub.com/content/15/5/18.full
AB  - Results from IMPROVE-IT showed that adding ezetimibe to statin therapy with simvastatin significantly reduced the primary end point in moderate- to high-risk patients stabilized after acute coronary syndromes. A new analysis from IMPROVE-IT showed that the number of first and recurrent primary end point events was also reduced with combination therapy vs monotherapy over the median 6-year follow-up.